Key result
Adiposity in large-for-gestational-age infants associates with smaller neonatal LV inflow and outflow dimensions.
Why the study?
Both excessive and restricted fetal growth are associated with changes in cardiac geometry and function at birth, and there are significant issues when indexing cardiac parameters for body size in neonates.
How does abnormal prenatal growth (SGA or LGA) affect cardiac geometry and function in neonates when adjusted for body size?
Cross-Sectional (n=174)
How does abnormal prenatal growth (SGA or LGA) affect cardiac geometry and function in neonates when adjusted for body size?
Cardiac geometry is largely explained by body size in AGA and SGA infants, but adiposity in LGA infants may lead to underestimation of left ventricular inflow and outflow tract dimensions when adjusted for BSA.
Adiposity may bias BSA-indexed LV dimensions in LGA neonates; leaves open optimal body-size adjustment for neonatal echocardiography.
OBJECTIVES: Both excessive and restricted fetal growth are associated with changes in cardiac geometry and function at birth. There are significant issues when indexing cardiac parameters for body size in the neonatal period. The aims of this study were to determine to what extent cardiac geometry is dependent on body size in term and preterm neonates with restricted or excessive fetal growth and how this is affected by adiposity. METHODS: This was a cross-sectional study of neonates born between 31 and 42 weeks of gestation, divided into three groups: (1) small-for-gestational age (SGA, birth weight > 2 SD below the mean); (2) large-for-gestational age (LGA, birth weight > 2 SD above the mean); and (3) appropriate-for-gestational-age controls (AGA, birth weight ≤ 2 SD from the mean). Cardiac geometry and function were compared between the study groups, adjusting for body size. The potential impact of infant adiposity and maternal disease was assessed. RESULTS: In total, 174 neonates were included, of which 39 were SGA, 45 were LGA and 90 were AGA. Body size was reflected in cardiac dimensions, with differences in cardiac dimensions disappearing between the SGA and AGA groups when indexed for body surface area (BSA) or thoracic circumference. The same was true for the differences in atrial and ventricular areas between the LGA and AGA groups. However, left ventricular inflow and outflow tract dimensions did not follow this trend as, when indexed for BSA, they were associated negatively with adiposity, resulting in diminished dimensions in LGA compared with AGA and SGA neonates. Adiposity was associated positively with left ventricular mass, right ventricular length and area and right atrial area. The SGA group showed increased right ventricular fractional area change, possibly reflecting differences in the systolic function of the right ventricle. We found evidence of altered diastolic function between the groups, with the mitral valve inflow E- to lateral E'-wave peak velocity ratio being increased in the LGA group and decreased in the SGA group. CONCLUSIONS: Cardiac geometry is explained by body size in both term and preterm AGA and SGA infants. However, the nature of the relationship between body size and cardiac dimensions may be influenced by adiposity in LGA infants, leading to underestimation of left ventricular inflow and outflow tract dimensions when adjusted for BSA. Adjustments for thoracic circumference provide similar results to those for BSA.
No takes yet. Share an insight, caveat, or question.
Olander et al. (2020) conducted a cross-sectional in Abnormal prenatal growth (n=174). Abnormal fetal growth (SGA or LGA) and adiposity vs. Appropriate-for-gestational-age (AGA) controls was evaluated on Cardiac geometry and function adjusted for body size. Abnormal fetal growth and adiposity alter neonatal cardiac geometry, with adiposity in large-for-gestational-age infants negatively associating with left ventricular inflow and outflow dimensions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: